Mediolanum International Funds’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6M Sell
720,894
-652,204
-47% -$17.1M 0.15% 157
2026
Q1
$38.1M Buy
1,373,098
+1,220,491
+800% +$32.5M 0.4% 51
2025
Q4
$3.81M Buy
152,607
+16,317
+12% +$411K 0.04% 288
2025
Q3
$3.25M Buy
136,290
+4,456
+3% +$110K 0.03% 299
2025
Q2
$3.19M Sell
131,834
-35,893
-21% -$837K 0.04% 293
2025
Q1
$4.23M Sell
167,727
-61,637
-27% -$1.61M 0.06% 263
2024
Q4
$6.04M Sell
229,364
-42,503
-16% -$1.15M 0.08% 215
2024
Q3
$7.9M Buy
271,867
+79,671
+41% +$2.32M 0.11% 187
2024
Q2
$4.99M Sell
192,196
-62,584
-25% -$1.72M 0.08% 220
2024
Q1
$7.08M Buy
+254,780
New +$7.07M 0.12% 187

Other funds holding PFE

Mediolanum International Funds's PFE Position: Q2 2026 in Review

Mediolanum International Funds reduced its Pfizer (PFE) stake by 47% in Q2 2026, selling an estimated $17.1M and leaving 720,894 shares worth $17.6M. The position accounts for 0.15% of the portfolio, ranked #157.

Mediolanum International Funds first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $38.1M in Q1 2026. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Mediolanum International Funds held 720,894 shares of Pfizer worth $17.6M as of Q2 2026.
  • Mediolanum International Funds sold 652,204 Pfizer shares in Q2 2026, an estimated $17.1M.
  • Pfizer made up 0.15% of Mediolanum International Funds's portfolio in Q2 2026, its #157 holding.
  • Mediolanum International Funds first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Pfizer position peaked at $38.1M in Q1 2026.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.